The case for informative phase 2 trials in osteosarcoma

Katherine A. Janeway, Richard Gorlick

Research output: Contribution to journalComment/debate

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1022-1023
Number of pages2
JournalThe Lancet Oncology
Volume17
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Osteosarcoma

ASJC Scopus subject areas

  • Oncology

Cite this

The case for informative phase 2 trials in osteosarcoma. / Janeway, Katherine A.; Gorlick, Richard.

In: The Lancet Oncology, Vol. 17, No. 8, 01.08.2016, p. 1022-1023.

Research output: Contribution to journalComment/debate

Janeway, Katherine A. ; Gorlick, Richard. / The case for informative phase 2 trials in osteosarcoma. In: The Lancet Oncology. 2016 ; Vol. 17, No. 8. pp. 1022-1023.
@article{d9f298ef72ee40b9a73bcd42631f2a8e,
title = "The case for informative phase 2 trials in osteosarcoma",
author = "Janeway, {Katherine A.} and Richard Gorlick",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/S1470-2045(16)30293-5",
language = "English (US)",
volume = "17",
pages = "1022--1023",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "8",

}

TY - JOUR

T1 - The case for informative phase 2 trials in osteosarcoma

AU - Janeway, Katherine A.

AU - Gorlick, Richard

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=84995933315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995933315&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(16)30293-5

DO - 10.1016/S1470-2045(16)30293-5

M3 - Comment/debate

AN - SCOPUS:84995933315

VL - 17

SP - 1022

EP - 1023

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 8

ER -